Introducing Gene Therapy in Action, our latest blog-style publication spotlighting rare diseases and cancers. This week we are exploring Amyotrophic Lateral Sclerosis (ALS)

This document will provide an insight into best practices when recruiting members to your IRB board.

A very warm welcome to Chad Spruill, joining our CBS team as an Associate Partner & Gene Therapy Biosafety Officer.

We're excited to welcome our newest IRB members to our Board! Working to bring our researchers more services and compliant, efficient IRB reviews.

We are thrilled to have Danielle Trbovich join our team as our newest Recruiting and Business Services Specialist! We're excited to bring your expertise on board. Welcome to the team!

We are so excited that you have joined our growing IRB team, Zach. Quality is such an important factor in what we do every day.

We are excited to announce that Elena Mahrt is joining our IBC team as an Associate Partner and Gene Therapy Biosafety Officer! We're glad to have you, welcome to the team.

Learn how, where, and what to submit for your IRB review with our specialized guidance document!

Join us in celebrating our favorite work from home colleagues!

We are exhibiting at CSHEMA's 69th Annual Conference!

We are excited to announce that Emily Born is joining our IRB team!

A big congratulations to Dr. Caitlyn Hauke for her promotion to IBC Chair at Clinical Biosafety Services!

We are excited to welcome Alexandra Robinson Gantt to our IRB team today! Welcome aboard, we are thrilled to have you.

We are excited to be attending AAHRPP's annual conference this May!

CEO and Principal Partner Chris Jenkins is giving an XTalks webinar later this May!

Read more about Nicholas Noriea's presentation below.

Read the Director of IRB Operation's address below.

We're thrilled to announce that we're adding Fridays to our board meeting schedule.

This March, we welcome Shauna Pierce to our Client Success Team! We are thrilled to have you on board, welcome to the team.

We are proud to announce that company founder Chris Jenkins has received the 2021 John H. Richardson award from ABSA International.

Are HGTs hazardous drugs? This month, IBC Director Patrick Conley offered a comprehensive overview of the topic.

A very warm welcome to Amanda Wilson, joining the CBS team as an Administrative Assistant! We are excited to have you on board.

We are proud to share our colors to raise awareness for this globally-coordinated movement, which works towards achieving equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.

Congratulations to our COO Marala McCallister who has been nominated for the 2022 Compassionate Leader Award, hosted by the Compassionate Leaders Circle.

'Tis the season of giving! We're proudly partnering with St. Louis Children's Hospital to spread joy this Holiday Season.

This week, we warmly welcome our new Chief Financial Officer, Andrew Messick! We're thrilled to have you on board.

We're thrilled to announce our CEO Chris Jenkins is the newly appointed Chairperson for the Gene Therapy Network.

Five years ago today, CBS began operations!

We're thrilled to announce that Dr. Jenni Smith has joined our team as an Associate Partner & Gene Therapy Biosafety Officer!

A very warm welcome to Jessica Poole, our newest Biosafety Associate Partner!